2.要約中間連結財務諸表及び主な注記
(1)要約中間連結財政状態計算書
| | | (単位:千円) |
| 前連結会計年度 (2023年12月31日) | | 当中間連結会計期間 (2024年6月30日) |
資産 | | | |
非流動資産 | | | |
有形固定資産 | 5,238,673 | | 5,852,597 |
使用権資産 | 814,513 | | 1,039,450 |
のれん | 17,261,275 | | 19,738,788 |
無形資産 | 3,690,331 | | 4,832,568 |
持分法で会計処理されている投資 | 360,821 | | 433,608 |
繰延税金資産 | 304,436 | | 238,751 |
その他の金融資産 | 3,793,224 | | 5,990,704 |
その他の非流動資産 | 23,811 | | 19,223 |
非流動資産合計 | 31,487,087 | | 38,145,692 |
| | | |
流動資産 | | | |
棚卸資産 | 2,330,622 | | 2,976,150 |
営業債権及びその他の債権 | 3,973,476 | | 5,177,582 |
その他の金融資産 | 1,577,274 | | 4,939,911 |
その他の流動資産 | 1,392,881 | | 1,448,017 |
現金及び現金同等物 | 21,633,028 | | 16,306,208 |
流動資産合計 | 30,907,282 | | 30,847,870 |
資産合計 | 62,394,370 | | 68,993,563 |
| | | |
負債及び資本 | | | |
非流動負債 | | | |
借入金 | 1,600,000 | | 1,400,000 |
リース負債 | 150,276 | | 257,350 |
繰延税金負債 | 1,173,159 | | 1,422,003 |
その他の金融負債 | 15,139,232 | | 15,353,137 |
その他の非流動負債 | 85,146 | | 79,952 |
非流動負債合計 | 18,147,815 | | 18,512,444 |
| | | |
流動負債 | | | |
営業債務及びその他の債務 | 2,064,776 | | 2,203,039 |
借入金 | 1,300,000 | | 3,668,000 |
1年内返済予定の長期借入金 | 400,000 | | 400,000 |
リース負債 | 249,158 | | 294,648 |
未払法人所得税 | 2,187,700 | | 1,218,991 |
その他の金融負債 | 49,010 | | 1,099,386 |
その他の流動負債 | 1,943,131 | | 2,032,755 |
流動負債合計 | 8,193,776 | | 10,916,821 |
負債合計 | 26,341,592 | | 29,429,265 |
| | | |
資本 | | | |
資本金 | 13,052,056 | | 13,218,954 |
資本剰余金 | 7,397,974 | | 6,480,860 |
自己株式 | △15,302 | | △15,302 |
利益剰余金 | 8,790,563 | | 9,120,690 |
その他の資本の構成要素 | 4,569,122 | | 8,029,714 |
親会社の所有者に帰属する持分合計 | 33,794,414 | | 36,834,916 |
非支配持分 | 2,258,363 | | 2,729,380 |
資本合計 | 36,052,778 | | 39,564,297 |
資本及び負債の合計 | 62,394,370 | | 68,993,563 |
E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第7号参考様式 [IFRS](連結)(一般2Q)IFRStrueCTE2024-01-012024-06-30Q22024-12-312023-01-012023-06-302023-12-311falsefalsefalse216002022-12-31216002023-12-31216002023-01-012023-06-30216002023-06-30216002024-01-012024-06-30216002024-06-30216002024-08-14216002022-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002022-12-31jpigp_cor:ShareCapitalIFRSMember216002022-12-31jpigp_cor:CapitalSurplusIFRSMember216002022-12-31jpigp_cor:TreasurySharesIFRSMember216002022-12-31jpigp_cor:RetainedEarningsIFRSMember216002022-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002022-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002022-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002022-12-31jpigp_cor:NonControllingInterestsIFRSMember216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-01-012023-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-01-012023-06-30jpigp_cor:ShareCapitalIFRSMember216002023-01-012023-06-30jpigp_cor:CapitalSurplusIFRSMember216002023-01-012023-06-30jpigp_cor:TreasurySharesIFRSMember216002023-01-012023-06-30jpigp_cor:RetainedEarningsIFRSMember216002023-01-012023-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-01-012023-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-01-012023-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-01-012023-06-30jpigp_cor:NonControllingInterestsIFRSMember216002023-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-06-30jpigp_cor:ShareCapitalIFRSMember216002023-06-30jpigp_cor:CapitalSurplusIFRSMember216002023-06-30jpigp_cor:TreasurySharesIFRSMember216002023-06-30jpigp_cor:RetainedEarningsIFRSMember216002023-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-06-30jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-01-012024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002024-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-06-30jpigp_cor:ShareCapitalIFRSMember216002024-06-30jpigp_cor:CapitalSurplusIFRSMember216002024-06-30jpigp_cor:TreasurySharesIFRSMember216002024-06-30jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-06-30jpigp_cor:NonControllingInterestsIFRSMember216002023-01-012023-06-30jpcrp_cor:ReportableSegmentsMember216002023-01-012023-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002023-01-012023-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMember216002023-01-012023-06-30jpcrp_cor:ReconcilingItemsMember216002024-01-012024-06-30tse-scediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-06-30tse-scediffr-21600:MedicalDeviceReportableSegmentMember216002024-01-012024-06-30jpcrp_cor:ReconcilingItemsMember216002024-01-012024-06-30jpcrp_cor:ReportableSegmentsMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure